2024 iJURECON

Autism spectrum disorder (ASD) is a chronic neurodevelopmental disorder that has become a significant global health concern. The rising prevalence of ASD across many countries has impacted individual and family due to extensive medical care, behavioural therapies and educational support. Studies reported that early intervention may reduce the financial and social burden on families and healthcare. As ASD presents in diverse characteristics, the necessity for tailored specific interventions is required. Therefore, this study aims to conduct a scoping review of articles which have evaluated intervention for ASD. Articles with keywords, titles or abstracts and free access for full article containing the terms ‘Autism’ OR ‘Autism Spectrum Disorder’ OR ‘ASD’ AND ‘Intervention’ OR ‘Best Practices’ OR ‘strategies’ were identified from PubMed and ScienceDirect. Type of intervention and specific characteristic of ASD between 2020 to 2024 were extracted from selected articles. Of 1017 studies identified, 70 articles were selected. This review demonstrated the need for further studies to address several issues including specific target participants and effectiveness of each intervention towards mixed characteristics